Related Experiment Videos
Premalignant and early squamous cell carcinoma.
Anjali K Butani1, Anjali Butani, David M Arbesfeld
1Dermatology, New Jersey Medical, USA [corrected]
Clinics in Plastic Surgery
|April 9, 2005
Summary
Actinic keratosis (AK) is a precancerous skin condition that can progress to squamous cell carcinoma (SCC). Early treatment of AK and suspicious lesions is crucial to prevent invasive SCC development.
Area of Science:
- Dermatology
- Oncology
- Skin Cancer Research
Background:
- Actinic keratosis (AK) is a common, sun-induced precancerous epidermal neoplasm.
- AK represents an early stage in the progression to invasive squamous cell carcinoma (SCC).
- Bowen's disease (squamous cell carcinoma in situ) is also an intraepidermal SCC precursor.
Purpose of the Study:
- To highlight the clinical significance of actinic keratosis as a precursor to squamous cell carcinoma.
- To emphasize the importance of early detection and treatment for AK and suspicious skin lesions.
- To discuss current therapeutic mainstays for epidermal neoplasms.
Main Methods:
- Review of the natural history and progression of actinic keratosis to squamous cell carcinoma.
- Discussion of the role of p53 tumor suppressor gene mutations in SCC development.
- Overview of established destructive treatment modalities for AK and in situ SCC.
Main Results:
- Actinic keratosis and Bowen's disease are asymptomatic epidermal lesions.
- A significant proportion of SCCs exhibit p53 gene mutations.
- Early intervention is necessary to halt the progression to invasive SCC.
Conclusions:
- Actinic keratosis requires prompt treatment to prevent malignant transformation into invasive squamous cell carcinoma.
- Destructive therapies, including cryosurgery and electrodesiccation/curettage, are primary treatment options.
- Dermatological evaluation is essential for managing these precancerous skin conditions.